Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients.

Attaya H, Wysokinski WE, Bower T, Litin S, Daniels PR, Slusser J, Heit JA, McBane RD 2nd.

J Thromb Thrombolysis. 2013 Jan;35(1):100-6. doi: 10.1007/s11239-012-0787-6.

PMID:
22843195
2.

Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.

Daniels PR, McBane RD, Litin SC, Ward SA, Hodge DO, Dowling NF, Heit JA.

Thromb Res. 2009 Jul;124(3):300-5. doi: 10.1016/j.thromres.2009.01.011. Epub 2009 Feb 20.

PMID:
19232682
3.

Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.

Wysokinski WE, McBane RD, Daniels PR, Litin SC, Hodge DO, Dowling NF, Heit JA.

Mayo Clin Proc. 2008 Jun;83(6):639-45. doi: 10.4065/83.6.639. Erratum in: Mayo Clin Proc. 2008 Jul;83(7):851.

PMID:
18533080
4.

Predictors of major bleeding in peri-procedural anticoagulation management.

Tafur AJ, McBane R 2nd, Wysokinski WE, Litin S, Daniels P, Slusser J, Hodge D, Beckman MG, Heit JA.

J Thromb Haemost. 2012 Feb;10(2):261-7. doi: 10.1111/j.1538-7836.2011.04572.x.

5.

Periprocedural anticoagulation management of patients with venous thromboembolism.

McBane RD, Wysokinski WE, Daniels PR, Litin SC, Slusser J, Hodge DO, Dowling NF, Heit JA.

Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):442-8. doi: 10.1161/ATVBAHA.109.199406. Epub 2010 Feb 5.

6.

Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.

Spyropoulos AC, Turpie AG, Dunn AS, Spandorfer J, Douketis J, Jacobson A, Frost FJ; REGIMEN Investigators.

J Thromb Haemost. 2006 Jun;4(6):1246-52.

7.

Outcomes and total costs of outpatient vs. inpatient peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.

Attaya H, Shah ND, Wysokinski WE, Van Houten HK, Heit JA, McBane RD 2nd.

Int J Cardiol. 2013 Oct 15;168(6):5311-5. doi: 10.1016/j.ijcard.2013.08.010. Epub 2013 Aug 15.

PMID:
23998551
8.
9.

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.

Dentali F, Pignatelli P, Malato A, Poli D, Di Minno MN, Di Gennaro L, Rancan E, Pastori D, Grifoni E, Squizzato A, Siragusa S, Di Minno G, Ageno W.

Am J Hematol. 2012 Apr;87(4):384-7. doi: 10.1002/ajh.23119. Epub 2012 Feb 24. Erratum in: Am J Hematol. 2012 Jul;87(7):748. Grifoni, Elena [corrected to Grifoni, Elisa].

10.

Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.

Jaffer AK, Brotman DJ, Bash LD, Mahmood SK, Lott B, White RH.

Am J Med. 2010 Feb;123(2):141-50. doi: 10.1016/j.amjmed.2009.09.017.

PMID:
20103023
11.

Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.

Saccullo G, Malato A, Raso S, Santoro M, Zammit V, Casuccio A, Siragusa S.

Am J Hematol. 2012 Apr;87(4):388-91. doi: 10.1002/ajh.23122. Epub 2012 Feb 28.

12.
13.

Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.

Kovacs MJ, Kearon C, Rodger M, Anderson DR, Turpie AG, Bates SM, Desjardins L, Douketis J, Kahn SR, Solymoss S, Wells PS.

Circulation. 2004 Sep 21;110(12):1658-63. Epub 2004 Sep 13.

14.

Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.

Hammerstingl C, Omran H.

Europace. 2011 Sep;13(9):1304-10. doi: 10.1093/europace/eur107. Epub 2011 Apr 19.

PMID:
21508005
15.

The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).

Omran H, Bauersachs R, Rübenacker S, Goss F, Hammerstingl C.

Thromb Haemost. 2012 Jul;108(1):65-73. doi: 10.1160/TH11-12-0827. Epub 2012 Apr 26.

PMID:
22534746
16.

Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.

Jaffer AK, Ahmed M, Brotman DJ, Bragg L, Seshadri N, Qadeer MA, Klein A.

J Thromb Thrombolysis. 2005 Aug;20(1):11-6.

PMID:
16133889
17.

Peri-procedural bridging with low molecular weight heparin in patients receiving warfarin for venous thromboembolism: a pediatric experience.

Moruf A, Spyropoulos AC, Schardt TQ, Gibson E, Manco-Johnson MJ, Wang M, Goldenberg NA.

Thromb Res. 2012 Oct;130(4):612-5. doi: 10.1016/j.thromres.2012.06.010. Epub 2012 Jun 29.

18.

Risk of thromboembolism with short-term interruption of warfarin therapy.

Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM.

Arch Intern Med. 2008 Jan 14;168(1):63-9. doi: 10.1001/archinternmed.2007.23.

PMID:
18195197
19.
20.

Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patients.

Tafur AJ, Wysokinski WE, McBane RD, Wolny E, Sutkowska E, Litin SC, Daniels PR, Slusser JP, Hodge DO, Heit JA.

Ann Oncol. 2012 Aug;23(8):1998-2005. doi: 10.1093/annonc/mds058. Epub 2012 Apr 3.

PMID:
22473596

Supplemental Content

Support Center